Trial Profile
The efficacy and safety of enzalutamide in patients with non-muscle invasive bladder cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2020
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 16 Mar 2017 New trial record